Five New DartmouthX Courses Announced
January 28, 2016 | Dartmouth Now
Dartmouth engineering professor Rachel Obbard will teach “Materials in Gear”—sports gear, that is—as one of five new DartmouthX courses.
Trustees Establish School of Graduate and Advanced Studies
January 27, 2016 | Dartmouth Now
The school is Dartmouth's first new school in more than a century.
Dartmouth Professor Brian Pogue Inducted into Medical and Biological Engineering Elite
January 26, 2016 | AIMBE
The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Dartmouth engineering professor Brian Pogue to its College of Fellows.
Busted knees and broken legs: Why ACL ski injuries have skyrocketed and what you can do about it
January 24, 2016 | Pique
Professor Rick Greenwald weighs in on the importance of bindings that can better release your foot during a twist.
BESC study seeks nature’s best biocatalysts for biofuel production
January 14, 2016 | Oak Ridge National Laboratory
A team of researchers from five institutions, including Dartmouth engineering professor Lee Lynd, found that unconventional bacteria could help boost the efficiency of cellulosic biofuel production.
Thayer’s Board of Overseers Welcomes Two New Members
January 13, 2016
Thayer School is pleased to announce two additions to the Board of Overseers: Catherine Sellman '93 and Andrew Silvernail '94.
Introducing Dartmouth’s Three Newest Faculty Clusters
January 11, 2016 | Dartmouth Now
The clusters will strengthen fields in which Dartmouth has a history of achievement.
Are DOT’s Tarmac Delay Fines Actually Making Delays Longer?
January 11, 2016 | TravelPulse
A study by Dartmouth and MIT has shown that passengers faced longer overall delays after the U.S. DOT’s 2010 tarmac delay rule was instituted.
Study: tarmac stranding rule creating more delays
January 11, 2016 | ConsumerAffairs
Dartmouth-MIT researchers say it's another example of unintended consequences.
Dementia Discovery Fund Chooses Alector for First Investment
January 7, 2016 | The Wall Street Journal
Alector, founded by Professor Tillman Gerngross, is developing drugs to address what its founders believe could be the root cause of dementia.